A Study of GDC-0449 (Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer

This study is ongoing, but not recruiting participants.

Study NCT00636610 Information provided by Genentech

First Received: March 5, 2008 Last Updated: September 8, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	March 2011 (Final data collection date for primary outcome measure)